UAE – Cleveland Clinic Abu Dhabi’s Fatima bint Mubarak Center has earned a three-year accreditation from the Joint Commission International (JCI), boosting the organization’s reputation in cancer care.

The highly coveted JCI accreditation was awarded in recognition of the impactful work of Cleveland Clinic Abu Dhabi’s Fatima bint Mubarak Center.

In a public-facing note, Dr. Stephen Grobmyer, Institute Chair of the Oncology Institute at Cleveland Clinic Abu Dhabi, stated: “We are honored that the Fatima bint Mubarak Center has been recognized by the Joint Commission International for its remarkable efforts in enhancing the quality and safety of healthcare services rendered to our esteemed patients and the wider community.”

Cleveland Clinic Abu Dhabi, part of the M42 network, is home to a stand-alone and dedicated cancer center, Fatima bint Mubarak Center.

Cleveland Clinic Abu Dhabi’s Fatima bint Mubarak Center provides patients with access to diagnostics and treatment options through world-class facilities across 24 clinical departments.

As part of its commitment to transform cancer care in the United Arab Emirates, the Fatima bint Mubarak Center has invested heavily in research, innovation, and the latest medical technology.

The center offers a wide range of cancer subspecialties and programs including Endocrine Cancers, Gastrointestinal Cancers, Genitourinary Cancers, Neurological Cancers, and Thoracic Cancers, just to name a few.

Receiving the prestigious JCI recognition within the first year of operation strengthens Fatima bint Mubarak Center’s position as the benchmark for excellence and world-class care.

Undeniably, the JCI accreditation affirms the Fatima bint Mubarak Center team’s dedication to providing high-quality treatment and care options.

The JCI accreditation is a testament to the hard work and dedication of our multidisciplinary teams and their steadfast focus on providing the best possible care to our patients—from day one,” noted Dr. Stephen Grobmyer.

This recognition, which is an extension of Cleveland Clinic Abu Dhabi’s accreditation, is expected to build on the center’s ongoing endeavors to emerge as a pioneer in cutting-edge cancer care in the UAE and wider region.

As the leading international accrediting body, JCI accreditation and recognition is a mark of excellence in the safety and quality of care provided by a healthcare organization.

To achieve JCI accreditation, an organization must undergo a rigorous performance assessment against a set of robust international standards.

The SAFER Matrix is a robust tool used by the JCI to identify and categorize risk factors related to the safety of patients, staff, and visitors.

The standards intend to promote continuous, systematic, and organization-wide improvement in daily performance and the outcomes of patient care.

Irrefutably, the three-year accreditation earned by Fatima bint Mubarak Center from the Joint Commission International stands as a testament to the center’s commitment to excellence in healthcare.

Fatima bint Mubarak Center is a newcomer to the UAE healthcare landscape. Being recognized by the world’s preeminent international accreditation body further cements our position as a healthcare leader providing world-class care closer to home,” underscored Dr. Grobmyer.

In another remarkable feat, Cleveland Clinic Abu Dhabi’s Fatima bint Mubarak Center achieved a gold standard in Leadership in Energy and Environmental Design (LEED).

LEED is a globally recognized symbol of sustainability achievement, as defined by the United States Green Building Council.

Fatima bint Mubarak Center received the LEED Gold from the United States Green Building Council, in recognition of its commitment to sustainability and environmental responsibility.

With cutting-edge diagnostic and treatment options, and a team of world-renowned multidisciplinary experts, the center continues to advance in becoming the best oncology facility in the UAE. 

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.